HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sparks, R. B. Articles by Siegel, J. A. Search for Related Content PubMed PubMed Citation Articles by Sparks, R. B. Articles by Siegel, J. A.

Radiation Dose Distributions in Normal Tissue Adjacent to Tumors Containing ¹³¹I or ⁹⁰Y: The Potential for Toxicity

¹ CDE Dosimetry Services, Inc., Knoxville, Tennessee
² Department of Nuclear Medicine, M.D. Anderson Cancer Center, Houston, Texas
³ Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee
⁴ Nuclear Physics Enterprises, Cherry Hill, New Jersey

Given the relatively large tumor-absorbed doses reported for patients receiving radionuclide therapy, particularly radioimmunotherapy, and the relatively long pathlength of the nonpenetrating emissions of some radionuclides being used for these therapies, there exists the possibility of large absorbed doses to tissues adjacent to, surrounded by, or surrounding these tumors. Because tumors can occur adjacent to critical organs or tissues, such as arteries, nerves, pericardium, and the walls of the organs of the gastrointestinal tract, large absorbed doses to these normal tissues can lead to acute complications. Methods: In this study, the Monte Carlo radiation transport code MCNP4b was used to simulate the deposition of energy from emissions of 2 radionuclides of interest, ¹³¹I and ⁹⁰Y, to assess the possible magnitude of the absorbed doses in tissues adjacent to tumors. Mathematic models were constructed to simulate situations that might occur, such as tumor wrapped around a small cylinder (e.g., a nerve or artery), tumor against a tissue (e.g., the pericardium or wall of any gastrointestinal tract organ), and tumor surrounded by any soft tissue. Tumor masses of 10, 20, and 40 g were used in each model. Depth dose distributions were calculated using Monte Carlo simulations of the radiation transport in these geometric models. Results: For tissues close to tumors containing ⁹⁰Y, the absorbed dose ranged from 24% of the absorbed dose in the tumor, for the case of tissues 1 mm from the tumor, to 103% of the absorbed dose in the tumor, for the case of small structures such as nerves or arteries surrounded by tumor. For tissues close to tumors containing ¹³¹I, the absorbed dose ranged from 4% of the absorbed dose in the tumor, for the case of tissues 1 mm from the tumor, to 46% of the absorbed dose in the tumor, for the case of small structures such as nerves or arteries surrounded by tumor. Conclusion: This study showed that when absorbed doses to tumors are large, the absorbed dose to adjacent tissues can also be large, potentially causing unexpected toxicities.

Key Words: dosimetry • radioimmunotherapy • tumors • absorbed-dose profile • tissue toxicity

This article has been cited by other articles:

				D. Sudheendra, M. M. Barth, U. Hegde, W. H. Wilson, and B. J. Wood Radiofrequency ablation of lymphoma Blood, February 15, 2006; 107(4): 1624 - 1626. [Abstract] [Full Text] [PDF]

				M. de Jong, W. A.P. Breeman, R. Valkema, B. F. Bernard, and E. P. Krenning Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs J. Nucl. Med., January 1, 2005; 46(1_suppl): 13S - 17S. [Abstract] [Full Text] [PDF]